RxDoctor Payments Data

J Riley Stringham, MD

Interventional Pain Medicine · Provo, UTNPI 1588872691

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (58.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by International Rehabilitative Sciences, Inc at 58.2% of the total. Reporting peaked in 2024 at $8,073 and has fallen 91.9% since, to $657 in 2025.

$13,065in general payments, 2019–2025

Across 197 payments — averaging $66.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • International Rehabilitative Sciences, Inc$8K
  • Vertiflex, Inc.$2K
  • Boston Scientific$479
  • Abbott$432
  • Medtronic$381
  • Nevro Corp.$377
  • plus $2K from 32 others

What the payments were for

  • Travel & lodging$1,43411%
  • Food & beverage$4,04331%
  • Other$7,58958%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,065 in reported general payments places this provider in the 75th percentile of 26 interventional pain medicine providers in Utah.

See all interventional pain medicine providers in Utah

Medicare billing

Part B allowed, 2024
$495,603
Medicare patients
590
Services billed
16,693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin43$740
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen43$567
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$536
Pregabalin13$241
Celecoxib13$160
Tizanidine Hcl24$152
Clindamycin Hcl13$126
Tramadol Hcl20$114
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim20$105
Promethazine Hcl12$47

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →